Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 26787-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- YTHDF1 antibody
- Antibody type
- Polyclonal
- Description
- YTHDF1 antibody (Cat. #26787-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Helicobacter pylori infection aggravates hepatic steatosis by lactylation-driven WTAP-mediated m(6)A modification.
RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis.
YTHDF1 in periaqueductal gray inhibitory neurons contributes to morphine withdrawal responses in mice.
DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma.
BIRC5 facilitates cisplatin-chemoresistance in a m(6)A-dependent manner in ovarian cancer.
Wnt3a/YTHDF1 Regulated Oxaliplatin-Induced Neuropathic Pain Via TNF-α/IL-18 Expression in the Spinal Cord.
Chen H, Wang Z, Wang Y, Li S, Su W, Shao Y, Zhang G, Liu Y, Ye Q, Zhou X
Gut microbes 2025 Dec 31;17(1):2599543
Gut microbes 2025 Dec 31;17(1):2599543
RUVBL1/2 Blockade Targets YTHDF1 Activity to Suppress m6A-Dependent Oncogenic Translation and Colorectal Tumorigenesis.
Chen D, Ji F, Zhou Q, Cheung H, Pan Y, Lau HC, Liang C, Yang Z, Huang P, Wei Q, Cheung AH, Kang W, Chen H, Yu J, Wong CC
Cancer research 2024 Sep 4;84(17):2856-2872
Cancer research 2024 Sep 4;84(17):2856-2872
YTHDF1 in periaqueductal gray inhibitory neurons contributes to morphine withdrawal responses in mice.
Ou C, Zhang K, Mu Y, Huang Z, Li X, Huang W, Wang Y, Zeng W, Ouyang H
BMC medicine 2024 Sep 20;22(1):406
BMC medicine 2024 Sep 20;22(1):406
DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma.
Fan W, Xing Y, Yan S, Liu W, Ning J, Tian F, Wang X, Zhan Y, Luo L, Cao M, Huang J, Cai L
Cancer cell international 2024 Jun 13;24(1):208
Cancer cell international 2024 Jun 13;24(1):208
BIRC5 facilitates cisplatin-chemoresistance in a m(6)A-dependent manner in ovarian cancer.
Fan Y, Pan Y, Jia L, Gu S, Liu B, Mei Z, Lv C, Huang H, Zhu G, Deng Q
Cancer medicine 2024 Jan;13(1):e6811
Cancer medicine 2024 Jan;13(1):e6811
Wnt3a/YTHDF1 Regulated Oxaliplatin-Induced Neuropathic Pain Via TNF-α/IL-18 Expression in the Spinal Cord.
Bai X, Huang Y, Huang W, Zhang Y, Zhang K, Li Y, Ouyang H
Cellular and molecular neurobiology 2023 May;43(4):1583-1594
Cellular and molecular neurobiology 2023 May;43(4):1583-1594
No comments: Submit comment
No validations: Submit validation data